Form D · Private Equity Fund
Drug Royalty III (Feeder LU) Sarl
Luxembourg, N4 · CIK 0001570336
Offering snapshot reported Feb 22, 2013 · SEC filing
- Reported sold
- $300M Indefinite offering
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $10M Reported outside-investor minimum
- First sale
- Feb 8, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 22, 2013 | Initial | $300,000,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06, 3C, 3C.7
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $4.5M (estimated)
- Finders' fees
- $0 (estimated)
- Form D file number
- 021-192253
Commission contingent on certain milestones.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Atlantic-Pacific Capital, Inc. | 38356 |
Source: Form D, filed Feb 22, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ali Hedayat | Director |
| Behzad Khosrowshahi | Director |
| Gerard Matheis | Director |
| Sinan Sar | Director |
| Ali Seirafi | Director |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
7, Avenue Gaston Diderich
Luxembourg, N4, L-1420
Luxembourg, N4, L-1420